Narjust Florez/X
Dec 23, 2024, 14:05
Narjust Florez: Key takeaways from the Hear Her campaign
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center, shared a post on X:
“Key takeaways:
- The Hear Her campaign focuses on gender disparities in lung cancer diagnosis and clinical trial enrollment.
- Clinicians should take women’s concerns seriously and make use of imaging for early detection.
Article here.”
More posts featuring Narjust Florez.
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.
In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 14:05
Dec 23, 2024, 14:03
Dec 23, 2024, 13:24
Dec 23, 2024, 13:06
Dec 23, 2024, 12:55
Dec 23, 2024, 12:47
Dec 23, 2024, 12:47